A novel method for conserved sequence extraction with prospective mutation prediction for SARS-CoV-2 PCR primer design.


Journal

Journal of virological methods
ISSN: 1879-0984
Titre abrégé: J Virol Methods
Pays: Netherlands
ID NLM: 8005839

Informations de publication

Date de publication:
07 2021
Historique:
received: 10 07 2020
revised: 29 03 2021
accepted: 30 03 2021
pubmed: 5 4 2021
medline: 5 6 2021
entrez: 4 4 2021
Statut: ppublish

Résumé

While the whole genomic sequence of SARS-CoV-2 had been revealed, it was also demonstrated that the genome of SARS-CoV-2 exhibits identity with the genome of SARS-CoV and MERS-CoV with ratios of 80 % and 50 % respectively. In the light of SARS-CoV-2 infection and mortality data, diagnosis and treatment of COVID-19 came into prominence around the world. As such many RT-PCR kits have been developed by biotechnology scientists. However viruses are fast mutating organisms and in order to increase accuracy, feasibility in long term and avoid the off target results of RT-PCR assays, regions of viral genome with low mutation rate and designing of primers targeting these regions are quite important. In this scope, we are presenting a novel algorithm that could be used for finding low mutation rate regions of SARS-CoV-2 and primers that were designed according to findings from our algorithm in this study.

Identifiants

pubmed: 33812944
pii: S0166-0934(21)00085-9
doi: 10.1016/j.jviromet.2021.114146
pmc: PMC8015351
pii:
doi:

Substances chimiques

DNA Primers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114146

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

Can J Cardiol. 2020 Jun;36(6):915-930
pubmed: 32439306
J Endod. 2020 May;46(5):584-595
pubmed: 32273156
J Adv Res. 2020 Mar 16;24:91-98
pubmed: 32257431
Trends Immunol. 2020 May;41(5):355-359
pubmed: 32249063
J Microbiol Immunol Infect. 2021 Apr;54(2):159-163
pubmed: 32265180
Infect Genet Evol. 2020 Sep;83:104353
pubmed: 32387562
Bioinformatics. 2002 Nov;18(11):1544-5
pubmed: 12424130
J Am Coll Radiol. 2020 Apr;17(4):447-451
pubmed: 32092296
J Mol Evol. 1994 Sep;39(3):306-14
pubmed: 7932792
Mol Biol Evol. 1989 May;6(3):270-89
pubmed: 2622335
Viruses. 2010 Sep;2(9):1867-1885
pubmed: 21994712
J Autoimmun. 2020 May;109:102434
pubmed: 32143990
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10915-9
pubmed: 1438297
Mol Biol Evol. 2018 Jun 1;35(6):1547-1549
pubmed: 29722887
Acta Pharm Sin B. 2020 May;10(5):766-788
pubmed: 32292689
Bioinformatics. 2018 Jun 1;34(11):1937-1938
pubmed: 29360956
Int J Infect Dis. 2020 May;94:119-124
pubmed: 32247050
Cell Host Microbe. 2020 Apr 8;27(4):671-680.e2
pubmed: 32183941
J Virol. 2018 Jun 29;92(14):
pubmed: 29720522
BMC Bioinformatics. 2009 Dec 15;10:421
pubmed: 20003500
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W306-10
pubmed: 15980478
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855

Auteurs

Saygın Hüseyin Portakal (SH)

Izmir University of Economics, Faculty of Engineering, Department of Biomedical Engineering, Izmir, Turkey.

Beyza Kanat (B)

Izmir University of Economics, Faculty of Engineering, Department of Biomedical Engineering, Izmir, Turkey.

Murat Sayan (M)

Kocaeli University, Faculty of Medicine, Clinical Laboratory, PCR Unit, Kocaeli, Turkey; Turkish Republic of Northern Cyprus.

Burak Berber (B)

Eskisehir Technical University, Faculty of Science, Department of Biology, Eskisehir, Turkey.

Osman Doluca (O)

Izmir University of Economics, Faculty of Engineering, Department of Biomedical Engineering, Izmir, Turkey. Electronic address: osman.doluca@ieu.edu.tr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH